ArticleCureus2026
Role of Otolaryngology in Monitoring the Progression of Myotonic Dystrophy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myotonic dystrophy is a systemic condition with the involvement of the neuromuscular, cardiac, and gastrointestinal systems. Otolaryngology has an underrecognized yet critical role in the longitudinal management of myotonic dystrophy, given the impact on swallowing, voice, and airway management. This case is of a 42-year-old male with genetically confirmed myotonic dystrophy type one. The patient presented with complaints of dysphagia, voice changes, and hand weakness. Though this patient's workup primarily focused on internal medicine and gastroenterology, these quality-of-life complaints highlight a realm where otolaryngology monitoring and evaluation can contribute to early recognition and management of aspiration risk, vocal dysfunction, airway management, and sleep apnea, ultimately improving quality of life. This shows the value of a multidisciplinary team, including otolaryngology, in promoting the overall health and quality-of-life goals of patients with myotonic dystrophy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.